HLS.TO
HLS Therapeutics Inc
Price:  
3.65 
CAD
Volume:  
1,600.00
Canada | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HLS.TO WACC - Weighted Average Cost of Capital

The WACC of HLS Therapeutics Inc (HLS.TO) is 5.7%.

The Cost of Equity of HLS Therapeutics Inc (HLS.TO) is 6.75%.
The Cost of Debt of HLS Therapeutics Inc (HLS.TO) is 5.00%.

Range Selected
Cost of equity 5.60% - 7.90% 6.75%
Tax rate 3.00% - 5.10% 4.05%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.2% - 6.2% 5.7%
WACC

HLS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.49 0.62
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 7.90%
Tax rate 3.00% 5.10%
Debt/Equity ratio 1.15 1.15
Cost of debt 5.00% 5.00%
After-tax WACC 5.2% 6.2%
Selected WACC 5.7%